Patents by Inventor Scott M. Duncan

Scott M. Duncan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline salt forms
    Patent number: 12252553
    Abstract: Disclosed are various crystalline salt forms of D-Arg-Dmt-Lys-Phe-NH2.
    Type: Grant
    Filed: December 2, 2022
    Date of Patent: March 18, 2025
    Assignee: Stealth BioTherapeutics Inc.
    Inventors: Scott M. Duncan, Martin P. Redmon
  • Automated Methods and Apparatus for Installing Sleeves on Shielded Electrical Cables
    Publication number: 20250079050
    Abstract: An automated apparatus for installing a sleeve on a cable includes a split funnel assembly, a cable feeding mechanism, a robot comprising a robot tool mounting flange and a plurality of robot motors, a sleeve gripper mounted to the robot tool mounting flange, a plurality of heaters, and a computer configured to output commands in accordance with a predetermined computer program. The split funnel assembly includes an actuator and a split funnel comprising a pair of funnel halves which are able to open and close in response to activation of the actuator. Each funnel half comprises a cable guide channel and a funnel extension. While the split funnel is in the funnel closed state, the funnel extensions form a seat for the sleeve and the cable guide channels form a repeatable path for the cable to follow through the funnel. The apparatus further includes a cable centering gripper, a cable clamp assembly, a slug puller assembly, and a ground lead management system.
    Type: Application
    Filed: September 1, 2023
    Publication date: March 6, 2025
    Applicant: The Boeing Company
    Inventors: Grace L. Duncan, Bradley J. Mitchell, Scott M. Beute, Mary Fundenberger, David J. TerHaar, Kevin M. Barrick, Christopher T. Cudney, Matt Michmerhuizen
  • Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH
    Patent number: 12110345
    Abstract: Disclosed are various crystalline salt forms of Boc-D-Arg-DMT-Lys(Boc)-Phe-NH2.
    Type: Grant
    Filed: August 8, 2023
    Date of Patent: October 8, 2024
    Assignee: Stealth BioTherapeutics Inc.
    Inventor: Scott M. Duncan
  • Crystalline dipeptides useful in the synthesis of elamipretide
    Patent number: 12018094
    Abstract: Disclosed are crystalline forms of L-Lys(Boc)-Phe-NH2 and Boc-D-Arg-DMT. The crystalline forms may be used in the synthesis of elamipretide.
    Type: Grant
    Filed: December 21, 2022
    Date of Patent: June 25, 2024
    Assignee: Stealth BioTherapeutics Inc.
    Inventors: Scott M. Duncan, Martin P. Redmon
  • CRYSTALLINE SALT FORMS OF BOC-D-ARG-DMT-LYS-(BOC)-PHE-NH2
    Publication number: 20240140990
    Abstract: Disclosed are various crystalline salt forms of Boc-D-Arg-DMT-Lys(Boc)-Phe-NH2.
    Type: Application
    Filed: August 8, 2023
    Publication date: May 2, 2024
    Inventor: Scott M. Duncan
  • Capsaicinoid prodrug compounds and their use in treating medical conditions
    Patent number: 11820727
    Abstract: The invention provides capsaicinoid prodrug compounds, pharmaceutical compositions, and their use in the treatment of medical conditions, such as pain, and in agonizing TRPV1 activity.
    Type: Grant
    Filed: June 29, 2022
    Date of Patent: November 21, 2023
    Assignee: Centrexion Therapeutics Corporation
    Inventors: James N. Campbell, Scott M. Duncan
  • Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH
    Patent number: 11773136
    Abstract: Disclosed are various crystalline salt forms of Boc-D-Arg-DMT-Lys(Boc)-Phe-NH2.
    Type: Grant
    Filed: April 8, 2021
    Date of Patent: October 3, 2023
    Assignee: Stealth BioTherapeutics Inc.
    Inventor: Scott M. Duncan
  • CRYSTALLINE SALT FORMS
    Publication number: 20230279049
    Abstract: Disclosed are various crystalline salt forms of D-Arg-Dmt-Lys-Phe-NH2.
    Type: Application
    Filed: December 2, 2022
    Publication date: September 7, 2023
    Inventors: Scott M. Duncan, Martin P. Redmon
  • CRYSTALLINE DIPEPTIDES USEFUL IN THE SYNTHESIS OF ELAMIPRETIDE
    Publication number: 20230203093
    Abstract: Disclosed are crystalline forms of L-Lys(Boc)-Phe-NH2 and Boc-D-Arg-DMT. The crystalline forms may be used in the synthesis of elamipretide.
    Type: Application
    Filed: December 21, 2022
    Publication date: June 29, 2023
    Inventors: Scott M. Duncan, Martin P. Redmon
  • Crystalline dipeptides useful in the synthesis of elamipretide
    Patent number: 11560404
    Abstract: Disclosed are crystalline forms of L-Lys(Boc)-Phe-NH2 and Boc-D-Arg-DMT. The crystalline forms may be used in the synthesis of elamipretide.
    Type: Grant
    Filed: April 7, 2021
    Date of Patent: January 24, 2023
    Assignee: Stealth BioTherapeutics Inc.
    Inventors: Scott M. Duncan, Martin P. Redmon
  • Crystalline salt forms
    Patent number: 11555053
    Abstract: Disclosed are various crystalline salt forms of D-Arg-Dmt-Lys-Phe-NH2.
    Type: Grant
    Filed: May 4, 2020
    Date of Patent: January 17, 2023
    Assignee: Stealth BioTherapeutics Inc.
    Inventors: Scott M. Duncan, Martin P. Redmon
  • Capsaicinoid prodrug compounds and their use in treating medical conditions
    Patent number: 11447444
    Abstract: The invention provides capsaicinoid prodrug compounds, pharmaceutical compositions, and their use in the treatment of medical conditions, such as pain, and in agonizing TRPV1 activity.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: September 20, 2022
    Assignee: Centrexion Therapeutics Corporation
    Inventors: James N. Campbell, Scott M. Duncan
  • Crystalline salt forms of SBT-20
    Patent number: 11325943
    Abstract: Disclosed are various crystalline salt forms of L-Phe-D-Arg-L-Phe-L-Lys-NH2.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: May 10, 2022
    Assignee: STEALTH BIOTHERAPEUTICS INC.
    Inventor: Scott M. Duncan
  • Crystalline bis- and tris-hydrochloride salt of elamipretide
    Patent number: 11261213
    Abstract: Disclosed are crystalline forms of the bis- and tris-(hydrochloride) salts of D-Arg-Tyr(2,6-DiMe)-Lys-Phe-NH2, which is also known as MTP-131.
    Type: Grant
    Filed: May 4, 2020
    Date of Patent: March 1, 2022
    Assignee: Stealth BioTherapeutics Inc.
    Inventor: Scott M. Duncan
  • Capsaicinoid prodrug compounds and their use in treating medical conditions
    Patent number: 11254659
    Abstract: The invention provides capsaicinoid prodrug compounds (e.g., prodrugs of resiniferatoxin, tinyatoxin, iodoresiniferatoxin, and related compounds), pharmaceutical compositions, and their use in the treatment of medical conditions, such as pain, and in agonizing TRPV1 activity.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: February 22, 2022
    Assignee: Centrexion Therapeutics Corporation
    Inventors: James N. Campbell, Scott M. Duncan
  • CRYSTALLINE SALT FORMS OF SBT-20
    Publication number: 20210292361
    Abstract: Disclosed are various crystalline salt forms of L-Phe-D-Arg-L-Phe-L-Lys-NH2.
    Type: Application
    Filed: June 1, 2018
    Publication date: September 23, 2021
    Inventor: Scott M. Duncan
  • CRYSTALLINE SALT FORMS OF BOC-D-ARG-DMT-LYS-(BOC)-PHE-NH2
    Publication number: 20210292362
    Abstract: Disclosed are various crystalline salt forms of Boc-D-Arg-DMT-Lys(Boc)-Phe-NH2.
    Type: Application
    Filed: April 8, 2021
    Publication date: September 23, 2021
    Inventor: Scott M. Duncan
  • CRYSTALLINE DIPEPTIDES USEFUL IN THE SYNTHESIS OF ELAMIPRETIDE
    Publication number: 20210292274
    Abstract: Disclosed are crystalline forms of L-Lys(Boc)-Phe-NH2 and Boc-D-Arg-DMT.
    Type: Application
    Filed: April 7, 2021
    Publication date: September 23, 2021
    Inventors: Scott M. Duncan, Martin P. Redmon
  • Crystalline salt forms of Boc-D-Arg-DMT-Lys-(Boc)-Phe-NH
    Patent number: 11034724
    Abstract: Disclosed are various crystalline salt forms of Boc-D-Arg-DMT-Lys(Boc)-Phe-NH2.
    Type: Grant
    Filed: April 4, 2018
    Date of Patent: June 15, 2021
    Assignee: Stealth BioTherapeutics Corp.
    Inventor: Scott M. Duncan
  • Crystalline dipeptides useful in the synthesis of elamipretide
    Patent number: 10975118
    Abstract: Disclosed are crystalline forms of L-Lys(Boc)-Phe-NH2 and Boc-D-Arg-DMT.
    Type: Grant
    Filed: March 28, 2019
    Date of Patent: April 13, 2021
    Assignee: Stealth BioTherapeutics Corp.
    Inventors: Scott M. Duncan, Martin P. Redmon